MHUAF · Meihua International Medical Technologies Co., Ltd.
Price & Indicators
Raw chart and full-history price indicators begin at the captured split on Nov 24, 2025; bars on opposite sides are not compared.
The closing range begins at the captured split on Nov 24, 2025.
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MHUAF
this stock
Meihua International Medical Technologies Co., Ltd.
|
$6.10M | +247.8% | -36.2% | — | 0.1% |
|
ISRG
Intuitive Surgical Inc
|
$130.45B | -34.3% | +20.5% | 42.4 | 2.0% |
|
BDX
Becton Dickinson & Co
|
$51.08B | — | +8.2% | — | 3.4% |
|
MDLN
Medline Inc.
|
$46.16B | -13.6% | +11.5% | — | 2.8% |
|
ALC
Alcon Inc
|
$34.92B | -8.3% | +10.5% | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
Raw-price comparisons begin at the captured split on Nov 24, 2025; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MHUAF | +4.7% | -20.8% | -43.2% | +4.9% | +247.8% |
| SPY | +1.1% | +4.0% | +14.7% | +3.2% | +13.1% |
| vs SPY | +3.6% | -24.8% | -57.9% | +1.6% | +234.7% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.